Jan van Breemen Institute

Summary

Organization: Jan van Breemen Institute
Country: The Netherlands

Top Publications

  1. ncbi Cost-effectiveness of antibiotic prophylaxis for bacterial arthritis
    Dirkjan van Schaardenburg
    Jan van Breemen Instituut, Centrum voor Reumatologie en Revalidatie, Dr Jan van Breemenstraat 2, NL 1056 AB, Amsterdam, The Netherlands
    Expert Opin Pharmacother 3:271-5. 2002
  2. ncbi Dealing with immunogenicity of biologicals: assessment and clinical relevance
    Gerrit J Wolbink
    Department of Rheumatology, Jan van Breemen Institute, Dr Jan van Breemenstraat 2, Amsterdam 1056 AB, The Netherlands
    Curr Opin Rheumatol 21:211-5. 2009
  3. pmc Different properties of ACPA and IgM-RF derived from a large dataset: further evidence of two distinct autoantibody systems
    Jennie Ursum
    Jan van Breemen Institute, 1056 AB Amsterdam, The Netherlands
    Arthritis Res Ther 11:R75. 2009
  4. doi First rehabilitation consultation in patients of non-native origin: factors that lead to tension in the patient-physician interaction
    M Sloots
    Department of Research and Education, Jan van Breemen Institute, Centre for Rheumatology and Rehabilitation, Amsterdam, The Netherlands
    Disabil Rehabil 31:1853-61. 2009
  5. doi Reproducibility of performance measures of physical function based on the BASFI, in ankylosing spondylitis
    Salima F E van Weely
    Jan van Breemen Institute, Centre for Rheumatology and Rehabilitation, Dr Jan van Breemenstraat 2, 1056 AB, Amsterdam, The Netherlands
    Rheumatology (Oxford) 48:1254-60. 2009
  6. doi Recreational exercise in rheumatic diseases
    J Holla
    Jan van Breemen Institute, Sports Centre, Amsterdam, Netherlands
    Int J Sports Med 30:814-20. 2009
  7. doi Interobserver reliability of the Amsterdam Severity Scale in Stenosing Tenosynovitis (ASSiST)
    Wilfred F H Peter
    Jan van Breemen Institute, Center for Rheumatology and Rehabilitation, Amsterdam, The Netherlands
    J Hand Ther 22:355-9; quiz 360. 2009
  8. doi Clinical approaches to early inflammatory arthritis
    Dirkjan van Schaardenburg
    Department of Rheumatology, Jan van Breemen Institute, Amsterdam, The Netherlands
    Nat Rev Rheumatol 5:627-33. 2009
  9. doi Circulating microparticles remain associated with complement activation despite intensive anti-inflammatory therapy in early rheumatoid arthritis
    I C van Eijk
    Correspondence to Dr M T Nurmohamed, Jan van Breemen Institute, Dr Jan van Breemenstraat 2, 1056 AB Amsterdam, The Netherlands
    Ann Rheum Dis 69:1378-82. 2010
  10. pmc Forefoot disease activity in rheumatoid arthritis patients in remission: results of a cohort study
    Marike van der Leeden
    Department of Rehabilitation Medicine and Psychology, Jan van Breemen Institute, Jan van Breemenstraat 2, 1056 AB Amsterdam, The Netherlands
    Arthritis Res Ther 12:R3. 2010

Scientific Experts

Detail Information

Publications34

  1. ncbi Cost-effectiveness of antibiotic prophylaxis for bacterial arthritis
    Dirkjan van Schaardenburg
    Jan van Breemen Instituut, Centrum voor Reumatologie en Revalidatie, Dr Jan van Breemenstraat 2, NL 1056 AB, Amsterdam, The Netherlands
    Expert Opin Pharmacother 3:271-5. 2002
    ..On the other hand, prophylaxis around medical or dental procedures was not cost-effective, except possibly in a small group of patients with increased risk...
  2. ncbi Dealing with immunogenicity of biologicals: assessment and clinical relevance
    Gerrit J Wolbink
    Department of Rheumatology, Jan van Breemen Institute, Dr Jan van Breemenstraat 2, Amsterdam 1056 AB, The Netherlands
    Curr Opin Rheumatol 21:211-5. 2009
    ..However, some patients do not respond to treatment and others lose their response after a certain time. Immunogenicity is one of the factors linked to secondary nonresponse but its clinical significance has remained controversial...
  3. pmc Different properties of ACPA and IgM-RF derived from a large dataset: further evidence of two distinct autoantibody systems
    Jennie Ursum
    Jan van Breemen Institute, 1056 AB Amsterdam, The Netherlands
    Arthritis Res Ther 11:R75. 2009
    ..The aim of this study was to examine seroconversion and the relationship with age and inflammation of autoantibodies in a large group of patients attending an outpatient rheumatology clinic...
  4. doi First rehabilitation consultation in patients of non-native origin: factors that lead to tension in the patient-physician interaction
    M Sloots
    Department of Research and Education, Jan van Breemen Institute, Centre for Rheumatology and Rehabilitation, Amsterdam, The Netherlands
    Disabil Rehabil 31:1853-61. 2009
    ..To explore which factors lead to tension in the patient-physician interaction in the first consultation by rehabilitation physicians of patients with chronic non-specific low back pain of Turkish and Moroccan origin...
  5. doi Reproducibility of performance measures of physical function based on the BASFI, in ankylosing spondylitis
    Salima F E van Weely
    Jan van Breemen Institute, Centre for Rheumatology and Rehabilitation, Dr Jan van Breemenstraat 2, 1056 AB, Amsterdam, The Netherlands
    Rheumatology (Oxford) 48:1254-60. 2009
    ..To establish the test-retest reproducibility of performance measures of physical function based on the Bath Ankylosing Spondylitis Functional Index (BASFI) questionnaire in patients with AS...
  6. doi Recreational exercise in rheumatic diseases
    J Holla
    Jan van Breemen Institute, Sports Centre, Amsterdam, Netherlands
    Int J Sports Med 30:814-20. 2009
    ..Regular participation in recreational exercise contributes to improved health-related quality of life in patients with rheumatic diseases...
  7. doi Interobserver reliability of the Amsterdam Severity Scale in Stenosing Tenosynovitis (ASSiST)
    Wilfred F H Peter
    Jan van Breemen Institute, Center for Rheumatology and Rehabilitation, Amsterdam, The Netherlands
    J Hand Ther 22:355-9; quiz 360. 2009
    ..Interobserver reliability study...
  8. doi Clinical approaches to early inflammatory arthritis
    Dirkjan van Schaardenburg
    Department of Rheumatology, Jan van Breemen Institute, Amsterdam, The Netherlands
    Nat Rev Rheumatol 5:627-33. 2009
    ..The success of early treatment of inflammatory arthritis and the recognition of a measurable preclinical phase of RA offer hope that treating the disease before it becomes clinically active might be possible...
  9. doi Circulating microparticles remain associated with complement activation despite intensive anti-inflammatory therapy in early rheumatoid arthritis
    I C van Eijk
    Correspondence to Dr M T Nurmohamed, Jan van Breemen Institute, Dr Jan van Breemenstraat 2, 1056 AB Amsterdam, The Netherlands
    Ann Rheum Dis 69:1378-82. 2010
    ..Therefore, we investigated whether circulating MPs differ between patients with very early as yet untreated arthritis and healthy controls, and whether intensive anti-inflammatory treatment of such patients affects circulating MPs...
  10. pmc Forefoot disease activity in rheumatoid arthritis patients in remission: results of a cohort study
    Marike van der Leeden
    Department of Rehabilitation Medicine and Psychology, Jan van Breemen Institute, Jan van Breemenstraat 2, 1056 AB Amsterdam, The Netherlands
    Arthritis Res Ther 12:R3. 2010
    ....
  11. doi Benefits of treatment theory in the design of explanatory trials: cognitive treatment of illness perception in chronic low back pain rehabilitation as an illustrative example
    Petra C Siemonsma
    Department of Rehabilitation Medicine and Psychology, Dr Jan van Breemen Institute, Dr Jan van Breemenstraat 2, NL 1056 AB Amsterdam, The Netherlands
    J Rehabil Med 42:111-6. 2010
    ..Treatment theory can assist in designing research that will provide results on which clinical decision-making can be based...
  12. pmc The value of ultrasonography in predicting arthritis in auto-antibody positive arthralgia patients: a prospective cohort study
    Lotte A van de Stadt
    Rheumatology, Jan van Breemen Institute, Dr Jan van Breemenstraat 2, 1056 AB, Amsterdam, The Netherlands
    Arthritis Res Ther 12:R98. 2010
    ..In the present study, US utility and predictive properties in arthralgia patients at risk for the development of arthritis were studied...
  13. doi Prognostic factors for the two-year course of activity limitations in early osteoarthritis of the hip and/or knee
    Jasmijn F M Holla
    Jan van Breemen Institute, Amsterdam, The Netherlands
    Arthritis Care Res (Hoboken) 62:1415-25. 2010
    ..To predict the 2-year course of activity limitations in patients with early knee and/or hip osteoarthritis (OA)...
  14. doi Prediction of walking disability by disease-related factors in patients with rheumatoid arthritis
    Marike van der Leeden
    Jan van Breemen Institute, Center for Rheumatology and Rehabilitation, Jan van Breemenstraat 2, 1056 AB Amsterdam, The Netherland
    J Rehabil Med 42:506-10. 2010
    ....
  15. doi Reasons of drop-out from rehabilitation in patients of Turkish and Moroccan origin with chronic low back pain in The Netherlands: a qualitative study
    Maurits Sloots
    Department of Rehabilitation Medicine, Jan van Breemen Institute for Rheumatology and Rehabilitation, Amsterdam, The Netherlands
    J Rehabil Med 42:566-73. 2010
    ..To explore which factors led to drop-out in patients of Turkish and Moroccan origin with chronic non-specific low back pain who participated in a rehabilitation programme...
  16. doi Measuring mobility limitations in children with cerebral palsy: development, scalability, unidimensionality, and internal consistency of the mobility questionnaire, MobQues47
    Leo D Roorda
    Department of Rehabilitation Medicine, VU University Medical Center, Amsterdam, The Netherlands
    Arch Phys Med Rehabil 91:1194-209. 2010
    ....
  17. doi Higher dropout rate in non-native patients than in native patients in rehabilitation in The Netherlands
    Maurits Sloots
    Jan van Breemen Institute, Centre for Rheumatology and Rehabilitation, The Netherlands
    Int J Rehabil Res 32:232-7. 2009
    ..Dropout is higher in the diagnostic phase than in the treatment phase and in rehabilitation centres than in hospitals. Future research should clarify the reasons for the high dropout rate in patients of non-native origin...
  18. doi Prevalence and course of forefoot impairments and walking disability in the first eight years of rheumatoid arthritis
    Marike van der Leeden
    Jan van Breemen Institute, Amsterdam, The Netherlands
    Arthritis Rheum 59:1596-602. 2008
    ..To evaluate the prevalence and 8-year course of forefoot impairments and walking disability in patients with rheumatoid arthritis (RA)...
  19. ncbi Cardiovascular risk profile of antirheumatic agents in patients with osteoarthritis and rheumatoid arthritis
    Michael T Nurmohamed
    Department of Rheumatology, VU University Medical Centre, Amsterdam, The Netherlands
    Drugs 62:1599-609. 2002
    ....
  20. ncbi Respiratory muscle performance as a possible determinant of exercise capacity in patients with ankylosing spondylitis
    Martin van der Esch
    Jan van Breemen Institute, Center for Rehabilitation and Rheumatology, Amsterdam, 1056 AB, The Netherlands
    Aust J Physiother 50:41-5. 2004
    ..5%, p = 0.05 respectively.) These data suggest respiratory pressure and respiratory muscle endurance, in particular maximal inspiratory pressure, may be determinants of exercise capacity in patients with ankylosing spondylitis...
  21. pmc Relationship between serum trough infliximab levels, pretreatment C reactive protein levels, and clinical response to infliximab treatment in patients with rheumatoid arthritis
    G J Wolbink
    Jan van Breemen Institute, Amsterdam, The Netherlands
    Ann Rheum Dis 64:704-7. 2005
    ..To investigate the relationship between serum trough infliximab levels and clinical response to infliximab treatment in patients with rheumatoid arthritis (RA)...
  22. ncbi Reproducibility of plantar pressure measurements in patients with chronic arthritis: a comparison of one-step, two-step, and three-step protocols and an estimate of the number of measurements required
    Marike van der Leeden
    Rehabilitation Department, Jan van Breemen Instituut, Centre for Rheumatology and Rehabilitation, 1056 AB Amsterdam, The Netherlands
    Foot Ankle Int 25:739-44. 2004
    ..In addition, the number of measurements needed for a consistent average was determined for the protocol that was found to be the most reproducible...
  23. ncbi Efficacy, tolerability and cost effectiveness of disease-modifying antirheumatic drugs and biologic agents in rheumatoid arthritis
    Michael T Nurmohamed
    Department of Rheumatology, VU University Medical Centre, Amsterdam, The Netherlands
    Drugs 65:661-94. 2005
    ..Unfortunately, adequate, prospective, economic evaluations are not yet available. Until these become available, treatment decisions will be based on the balance of direct costs and indirect costs and expected cost savings in the future...
  24. ncbi Forefoot joint damage, pain and disability in rheumatoid arthritis patients with foot complaints: the role of plantar pressure and gait characteristics
    M Van Der Leeden
    Jan van Breemen Institute, Center for Rehabilitation and Rheumatology, Jan van Breemenstraat 2, 1056 AB Amsterdam, The Netherlands
    Rheumatology (Oxford) 45:465-9. 2006
    ....
  25. ncbi Potential barriers to the use of health services among ethnic minorities: a review
    Emmanuel Scheppers
    JBI Institute for Rheumatology and Rehabilitation Medicine, Department of Research and Education Amsterdam, The Netherlands
    Fam Pract 23:325-48. 2006
    ..In order to enlighten care providers, as to the potential pitfalls that may exist, there is a need to explore the different factors in the creation of the barriers...
  26. ncbi The relationship of disease duration to foot function, pain and disability in rheumatoid arthritis patients with foot complaints
    M Van Der Leeden
    Jan van Breemen Institute, Center for Rehabilitation and Rheumatology, Amsterdam, The Netherlend
    Clin Exp Rheumatol 25:275-80. 2007
    ..To assess the relationship between disease duration and foot function (expressed as pressure and gait parameters), foot pain and disability, in patients with foot complaints secondary to rheumatoid arthritis (RA)...
  27. ncbi Varus-valgus motion and functional ability in patients with knee osteoarthritis
    M Van der Esch
    Jan van Breemen Institute, Center for Rheumatology and Rehabilitation Jan van Breemenstraat 2, 1056 AB Amsterdam, The Netherlands
    Ann Rheum Dis 67:471-7. 2008
    ....
  28. ncbi Knee varus-valgus motion during gait--a measure of joint stability in patients with osteoarthritis?
    M Van der Esch
    Jan van Breemen Institute, Center for Rheumatology and Rehabilitation, Amsterdam, The Netherlands
    Osteoarthritis Cartilage 16:522-5. 2008
    ....
  29. pmc Tracheobronchomalacia due to amyloidosis in a patient with rheumatoid arthritis
    Franktien Turkstra
    Department of Rheumatology, VU University Medical Center, Amsterdam, The Netherlands
    Clin Rheumatol 27:807-8. 2008
    ..Despite negative antemortem biopsies of abdominal fat and tongue, amyloid was found postmortem in the trachea and appeared to be associated with tracheobronchomalacia...
  30. pmc Antibodies to mutated citrullinated vimentin and disease activity score in early arthritis: a cohort study
    Jennie Ursum
    Jan van Breemen Institute, Dr Jan van Breemenstraat, 1056 AB Amsterdam, The Netherlands
    Arthritis Res Ther 10:R12. 2008
    ..The aim of our study was to investigate the association between arthritic disease activity and antibodies to mutated citrullinated vimentin (anti-MCV), because such a relation has been suggested...
  31. ncbi Differential response of the rheumatoid factor and anticitrullinated protein antibodies during adalimumab treatment in patients with rheumatoid arthritis
    Wouter H Bos
    Jan van Breemen Instituut, Sanquin Research, and VU University Medical Center, Department of Rheumatology, Amsterdam, The Netherlands
    J Rheumatol 35:1972-7. 2008
    ..To investigate the effect of anti-tumor necrosis factor (TNF) treatment on rheumatoid factor (IgM-RF) and anticitrullinated protein antibodies (ACPA) and its association with treatment response and acute-phase reactants...
  32. doi The benefits of theory for clinical practice: cognitive treatment for chronic low back pain patients as an illustrative example
    Petra C Siemonsma
    Dr Jan van Breemen Institute, Department of Rehabilitation Medicine and Psychology, Amsterdam, The Netherlands
    Disabil Rehabil 30:1309-17. 2008
    ..To demonstrate, with the help of an example of cognitive treatment for patients with chronic low back pain, how a systematic description of the content and theoretical underpinnings of treatment can help to improve clinical practice...
  33. doi Excellent cross-cultural validity, intra-test reliability and construct validity of the Dutch Rivermead Mobility Index in patients after stroke undergoing rehabilitation
    Leo D Roorda
    Department of Rehabilitation Medicine and Psychology, Jan van Breemen Institute, Dr J van Breemenstraat 2, 1056 AB Amsterdam, The Netherlands
    J Rehabil Med 40:727-32. 2008
    ..To investigate the cross-cultural validity of international Dutch-English comparisons when using the Dutch Rivermead Mobility Index (RMI), and the intra-test reliability and construct validity of the Dutch RMI...
  34. pmc The effect of immunomodulators on the immunogenicity of TNF-blocking therapeutic monoclonal antibodies: a review
    Charlotte Louise Maria Krieckaert
    Department of Rheumatology, Jan van Breemen Institute, Dr Jan van Breemenstraat 2, 1056 AB Amsterdam, The Netherlands
    Arthritis Res Ther 12:217. 2010
    ..The mechanism whereby methotrexate and azathioprine influence immunogenicity remains unclear. Evidence-based consensus on prescribing concomitant immunomodulators is needed...